The authors describe that CD36 deficiency: Naka-negative individuals do not express CD36 on their platelets (type I variant) or on their platelets and monocytes (type II variant). This may be predominantly due to a Pro90 to Ser substitution mutation, but as yet nophysiological problems have been associated with this deficiency. The type I variant in the above sentence should be changed to type II variant and the type I variant should be changed to type II variant. We have initially named type I and type II deficiency of CD36 deficiency in our article (Blood 83: 392-397, 1994) entitled "Platelet glycoprotein IV(CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes".
Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H and Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994 83:392 PubMed
Modified 10/14/99 mpr@mail.nih.gov